• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[治疗前PET-CT骨髓(18)F-FDG摄取模式在结外NK/T细胞淋巴瘤中的预后价值]

[Prognostic value of bone marrow (18)F-FDG uptake pattern of pretreatment PET-CT in extranodal NK/T cell lymphoma].

作者信息

Zhang Y, Zhou J, Wang L, Li J Y, Ding C Y

机构信息

Department of Radiology, Shuyang Traditional Chinese Medicine Hospital, Suqian 223600, China.

Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210009, China.

出版信息

Zhonghua Zhong Liu Za Zhi. 2020 Oct 23;42(10):885-890. doi: 10.3760/cma.j.cn112152-20191115-00739.

DOI:10.3760/cma.j.cn112152-20191115-00739
PMID:33113633
Abstract

To investigate the prognostic value of bone marrow (BM) (18)F-fluorodeoxyglucose ((18)F-FDG) uptake pattern of pretreatment positron emission tomography/computed tomography (PET-CT) in extranodal NK/T cell lymphoma (ENKTL) patients. We retrospectively collected clinical data from a series of 63 ENKTL patients with stageⅡ~Ⅳ, who have received both (18)F-FDG PET-CT and bone marrow biopsy (BMB) prior to treatment. According the BM (18)F-FDG uptake pattern of PET-CT, the patients were divided into three groups: focal BM FDG uptake higher than liver (fPET+ ), diffuse BM uptake higher than liver (dPET+ ) and normal BM uptake (lower than liver) (nPET). The Kaplan-Meier method and Log-rank test were respectively used for survival analysis and univariate analysis, and COX proportional hazards model for multivariate analysis. Among the 63 patients, 22 patients had nPET, 24 patients showed dPET+ , and 17 patients had fPET+ . BMB positive was found in 8 patients, and negative in 55 patients. Thirty-seven patients had disease progression or relapse, and 31 patients died. The 3-years progression free survival (3y-PFS) rates of fPET+ patients and nPET patients were 14.7% and 63.6% (=0.006). The 3-years overall survival (3y-OS) rates were 18.8% and 64.8% (=0.005). The 3y-PFS of dPET+ patients and nPET patients were 35.6% and 63.6% (=0.161), 3y-OS were 47.9% and 64.8% (=0.280). Univariate analysis showed that lactate dehydrogenase (LDH) level, Epstein-Barr virus DNA (EBV-DNA), Korean prognostic index (KPI) and BM (18)F-FDG were related with PFS and OS (all <0.05). Multivariate analysis showed EBV-DNA and BM (18)F-FDG were independent predictors for PFS (<0.05). EBV-DNA was also an independently predictor for OS (<0.05). PET/CT-directed BM patterns are meaningful in predicting prognosis of newly diagnosed ENKTL patients. Focal BM (18)F-FDG uptake pattern is an independent predictor for PFS.

摘要

探讨初治正电子发射断层扫描/计算机断层扫描(PET-CT)骨髓(BM)(18)F-氟脱氧葡萄糖((18)F-FDG)摄取模式在结外NK/T细胞淋巴瘤(ENKTL)患者中的预后价值。我们回顾性收集了63例Ⅱ~Ⅳ期ENKTL患者的临床资料,这些患者在治疗前均接受了(18)F-FDG PET-CT及骨髓活检(BMB)。根据PET-CT的BM(18)F-FDG摄取模式,将患者分为三组:局部BM FDG摄取高于肝脏(fPET+)、弥漫性BM摄取高于肝脏(dPET+)和正常BM摄取(低于肝脏)(nPET)。采用Kaplan-Meier法和Log-rank检验分别进行生存分析和单因素分析,采用COX比例风险模型进行多因素分析。63例患者中,22例为nPET,24例为dPET+,17例为fPET+。BMB阳性8例,阴性55例。37例患者疾病进展或复发,31例患者死亡。fPET+组和nPET组患者的3年无进展生存率(3y-PFS)分别为14.7%和63.6%(P=0.006)。3年总生存率(3y-OS)分别为18.8%和64.8%(P=0.005)。dPET+组和nPET组患者的3y-PFS分别为35.6%和63.6%(P=0.161),3y-OS分别为47.9%和64.8%(P=0.280)。单因素分析显示,乳酸脱氢酶(LDH)水平、爱泼斯坦-巴尔病毒DNA(EBV-DNA)、韩国预后指数(KPI)及BM(18)F-FDG与PFS和OS相关(均P<0.05)。多因素分析显示,EBV-DNA及BM(18)F-FDG是PFS的独立预测因素(P<0.05)。EBV-DNA也是OS的独立预测因素(P<0.05)。PET/CT引导的BM模式对预测新诊断ENKTL患者的预后具有重要意义。局部BM(18)F-FDG摄取模式是PFS的独立预测因素。

相似文献

1
[Prognostic value of bone marrow (18)F-FDG uptake pattern of pretreatment PET-CT in extranodal NK/T cell lymphoma].[治疗前PET-CT骨髓(18)F-FDG摄取模式在结外NK/T细胞淋巴瘤中的预后价值]
Zhonghua Zhong Liu Za Zhi. 2020 Oct 23;42(10):885-890. doi: 10.3760/cma.j.cn112152-20191115-00739.
2
[Diagnostic and Prognostic Value of F-FDG PET/CT in Bone Marrow Infiltration of Newly Diagnosed Diffuse Large B-Cell Lymphoma].[¹⁸F-FDG PET/CT在初诊弥漫性大B细胞淋巴瘤骨髓浸润中的诊断及预后价值]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2023 Aug;31(4):1044-1049. doi: 10.19746/j.cnki.issn.1009-2137.2023.04.018.
3
Prognostic Value of Bone Marrow FDG Uptake Pattern of PET/CT in Newly Diagnosed Diffuse Large B-cell Lymphoma.PET/CT检查中骨髓FDG摄取模式对初诊弥漫性大B细胞淋巴瘤的预后价值
J Cancer. 2018 Mar 14;9(7):1231-1238. doi: 10.7150/jca.23714. eCollection 2018.
4
[Prognostic value of pretreatment (18)F-FDG PET-CT metabolic parameters in patients with advanced extranodal NK/T cell lymphoma].[治疗前(18)F-FDG PET-CT代谢参数在晚期结外NK/T细胞淋巴瘤患者中的预后价值]
Zhonghua Zhong Liu Za Zhi. 2019 Nov 23;41(11):831-836. doi: 10.3760/cma.j.issn.0253-3766.2019.11.006.
5
[The Value of Baseline PET/CT Imaging of Bone Marrow F-FDG Uptake Pattern in Predicting Prognosis of DLBCL].[骨髓F-FDG摄取模式的基线PET/CT成像在预测弥漫性大B细胞淋巴瘤预后中的价值]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2024 Apr;32(2):439-444. doi: 10.19746/j.cnki.issn.1009-2137.2024.02.018.
6
Prognostic Importance of Bone Marrow Uptake on Baseline F-FDG Positron Emission Tomography in Diffuse Large B Cell Lymphoma.弥漫性大B细胞淋巴瘤患者基线F-FDG正电子发射断层扫描骨髓摄取的预后意义
Cancer Biother Radiopharm. 2016 Dec;31(10):361-365. doi: 10.1089/cbr.2016.2132.
7
Nomograms based on SUVmax of F-FDG PET/CT and clinical parameters for predicting progression-free and overall survival in patients with newly diagnosed extranodal natural killer/T-cell lymphoma.基于 F-FDG PET/CT 最大标准摄取值和临床参数的列线图预测初诊结外鼻型自然杀伤/T 细胞淋巴瘤患者的无进展生存和总生存。
Cancer Imaging. 2021 Jan 8;21(1):9. doi: 10.1186/s40644-020-00379-y.
8
Evaluation of bone marrow involvement in extranodal NK/T cell lymphoma by FDG-PET/CT.通过氟代脱氧葡萄糖正电子发射断层显像/X线计算机体层成像(FDG-PET/CT)评估结外NK/T细胞淋巴瘤的骨髓受累情况
Ann Hematol. 2015 Jun;94(6):963-7. doi: 10.1007/s00277-014-2289-4. Epub 2014 Dec 30.
9
Prognostic Value of Bone Marrow Tracer Uptake Pattern in Baseline PET Scans in Hodgkin Lymphoma: Results from an International Collaborative Study.基线 PET 扫描中骨髓示踪剂摄取模式对霍奇金淋巴瘤的预后价值:一项国际合作研究的结果。
J Nucl Med. 2017 Aug;58(8):1249-1254. doi: 10.2967/jnumed.116.184218. Epub 2017 Jan 26.
10
Assessment of the prognostic capacity of pretreatment, interim, and post-therapy (18)F-FDG PET/CT in extranodal natural killer/T-cell lymphoma, nasal type.评估治疗前、治疗中期及治疗后(18)F-FDG PET/CT对鼻型结外自然杀伤/T细胞淋巴瘤的预后判断能力。
Ann Nucl Med. 2015 Jun;29(5):442-51. doi: 10.1007/s12149-015-0964-8. Epub 2015 Mar 24.